Agios pharmaceuticals, inc. (AGIO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-358,650

-411,472

-400,916

-389,407

-348,281

-346,028

-342,519

-324,992

-339,329

-314,670

-282,871

-268,568

-241,439

-198,471

-182,607

-160,029

-135,973

-117,732

-103,774

-59,814

-46,213

-53,504

-39,222

-54,103

-44,427

-39,407

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

8,556

8,087

8,035

7,750

7,452

7,172

6,915

6,732

6,566

6,432

6,492

6,314

6,045

5,700

5,131

4,742

4,218

3,342

2,559

1,858

1,405

1,367

1,345

1,376

1,423

1,440

0

0

0

Stock-based compensation expense

73,955

72,373

73,430

79,035

76,943

73,357

67,851

55,865

51,597

47,809

44,968

44,904

43,713

42,086

41,599

38,829

36,010

31,963

27,338

20,857

15,061

11,506

7,943

6,163

4,111

3,030

0

0

0

Net accretion of premium and discounts on investments

1,938

3,195

4,069

4,565

4,562

3,837

2,576

1,396

580

11

-264

-537

-810

-773

-642

-550

-493

-539

-557

-552

-542

-538

-615

-598

-457

-284

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-40

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash operating lease expense

8,650

8,532

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

7,458

3,876

4,475

7,147

4,355

5,076

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivable – related party

258

-923

-1,557

-16,802

-1,193

14

-94

14,484

-7,753

-2,438

-4,693

-3,011

4,451

-3,339

-895

-2,621

-202

1,733

-9,682

10,474

4,397

6,016

0

0

0

-

-

-

-

Collaboration receivable – other

393

1,258

429

1,782

1,640

670

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty receivable – related party

1,100

666

737

1,127

783

1,012

1,148

1,573

1,417

1,222

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

7,450

6,462

4,986

4,659

2,328

869

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tenant improvement and other receivables

-

-

-

-

-

-

-

-

-

-

-

0

2,552

-

110

-3,268

-6,336

1,040

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other current and non-current assets

12,343

7,742

4,115

3,782

2,926

-1,148

3

-1,230

-1,726

3,600

1,842

3,708

4,988

2,420

3,915

5,022

3,917

3,768

2,439

1,962

2,656

2,878

0

0

0

-

-

-

0

Accounts payable

6,646

3,716

2,991

-1,164

-5,958

-5,488

-1,243

-5,799

1,854

5,329

2,575

4,676

2,800

3,501

7,207

9,180

6,587

4,215

3,899

4,683

4,192

7,577

3,562

1,985

-79

30

0

0

0

Accrued expenses

-2,637

7,233

21,762

23,535

20,670

8,623

-5,773

-3,927

-8,733

1,522

8,284

15,295

12,867

16,854

6,492

3,358

-2,843

1,633

4,286

3,803

8,999

5,231

5,812

1,903

2,383

4,878

0

0

0

Deferred revenue – related party

-72,380

-31,006

-41,765

-43,470

-43,915

-31,665

-22,178

-26,030

-27,787

-26,570

-40,287

-35,983

169,814

165,846

181,467

183,012

11,454

-14,047

-16,311

-28,344

-44,353

-19,228

-18,707

-9,834

-25,072

-25,072

0

0

0

Operating lease liabilities

-6,961

-6,861

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

82

154

1,092

1,832

2,729

3,339

1,120

-1,105

-1,346

-2,422

-2,929

-7,027

-15,805

-19,160

-17,435

-11,933

-3,691

0

0

0

-

-

0

0

Refundable income taxes and income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,841

3,841

3,841

4,496

-5,303

-8,987

-8,871

-9,436

-3,302

0

0

0

Net cash used in operating activities

-372,709

-370,622

-351,198

-329,448

-308,692

-304,421

-304,688

-318,564

-310,158

-285,232

-262,001

-233,316

-16,503

38,562

59,256

83,471

-70,373

-76,949

-54,195

-52,847

-57,898

-59,353

-65,195

-56,708

-71,459

-56,400

0

0

0

Investing activities
Proceeds from maturities and sales of marketable securities

548,867

592,177

642,582

678,187

712,421

666,481

627,586

663,376

663,707

635,421

570,300

447,875

334,349

396,632

492,112

556,040

616,207

501,650

680,009

608,105

567,279

505,528

175,865

117,541

62,460

60,126

0

0

0

Investing activities
Purchases of marketable securities

466,056

488,566

372,774

484,887

679,770

933,320

839,545

812,810

992,933

688,702

743,005

748,334

321,644

506,067

502,107

473,261

528,814

353,177

840,493

817,086

837,933

837,219

241,934

249,192

164,946

146,049

0

0

0

Purchases of property and equipment

14,588

12,171

6,400

7,502

7,592

6,986

7,213

6,092

5,766

4,627

4,569

5,976

7,675

9,915

10,879

10,752

18,900

20,164

19,467

16,796

6,000

2,216

946

417

1,032

1,294

0

0

0

Net cash provided by investing activities

68,223

91,440

263,408

185,798

25,059

-273,825

-219,172

-155,526

-334,992

-57,908

-177,274

-306,435

5,030

-119,350

-20,874

72,027

68,493

128,309

-179,951

-225,206

-276,083

-333,336

-66,444

-132,068

-103,518

-87,217

0

0

0

Financing activities
Proceeds from public offering of common stock, net of reimbursements

-

-

-

-

-

516,206

516,206

516,206

786,456

270,250

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on financing lease obligations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reimbursement (payment) of public offering costs

-

-

-

-

-

391

940

1,133

726

638

0

0

0

-

-

-

-

207

0

0

0

-

-

-

-

-

-

-

-

Net proceeds from stock option exercises and employee stock purchase plan

13,128

12,523

13,021

16,907

22,810

30,209

31,055

29,347

22,335

14,222

16,459

12,146

10,896

7,858

5,046

6,017

5,659

6,580

6,180

4,387

3,750

2,303

1,466

1,114

707

150

0

0

0

Net cash provided by financing activities

290,136

289,611

13,021

16,907

22,607

546,024

547,597

545,696

809,341

285,110

286,514

444,420

172,716

169,778

167,072

6,017

5,659

6,373

244,145

242,339

336,400

335,160

95,677

219,542

124,437

123,880

0

0

0

Net change in cash and cash equivalents

-14,350

10,429

-74,769

-126,743

-261,026

-32,222

23,737

71,606

164,191

-58,030

-152,761

-95,331

161,243

88,990

205,454

161,515

3,779

57,733

9,999

-35,714

2,419

-57,529

-35,962

30,766

-50,540

-19,737

0

0

0

Supplemental cash flow information
Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,980

0

0

0

-

-

-

-

Supplemental disclosure of non-cash investing and financing transactions
Vesting of restricted stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

10

11

8

9

0

0

0

-

-

-

0

Additions to property and equipment in accounts payable and accrued expenses

9,885

5,168

2,694

276

1,228

1,106

1,286

993

1,403

1,011

-198

96

-321

73

1,580

1,992

-3,832

2,163

3,001

3,637

8,707

2,118

0

0

0

-

-

-

-

Proceeds from stock option exercises in other current assets

-1,149

0

-32

119

1,083

7

-56

-3

67

0

127

12

21

32

-14

206

143

186

0

0

0

-

-

-

-

-

-

-

-

Operating lease liabilities arising from obtaining operating lease assets

42,322

42,322

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liabilities arising from obtaining financing lease assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs in other current assets, net of amounts in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-171

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-